Fidelity Investments
TMDX icon

Fidelity Investments’s Transmedics TMDX Stock Holding History

Fidelity Investments’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$507M Buy
5,096,243
+19,207
+0.4% +$2.51M 0.03% 507
2025
Q4 		$618M Buy
5,077,036
+12,666
+0.3% +$1.59M 0.03% 435
2025
Q3 		$568M Buy
5,064,370
+40,630
+0.8% +$4.76M 0.03% 450
2025
Q2 		$673M Buy
5,023,740
+25,731
+0.5% +$2.83M 0.04% 388
2025
Q1 		$336M Buy
4,998,009
+990,562
+25% +$68.1M 0.02% 611
2024
Q4 		$250M Buy
4,007,447
+1,875,101
+88% +$175M 0.01% 730
2024
Q3 		$335M Sell
2,132,346
-2,357,858
-53% -$363M 0.02% 624
2024
Q2 		$676M Sell
4,490,204
-348,676
-7% -$41.8M 0.04% 346
2024
Q1 		$358M Buy
4,838,880
+10,136
+0.2% +$835K 0.02% 567
2023
Q4 		$381M Buy
4,828,744
+113,874
+2% +$6.87M 0.03% 509
2023
Q3 		$258M Buy
4,714,870
+1,407,171
+43% +$101M 0.02% 603
2023
Q2 		$278M Buy
3,307,699
+51,428
+2% +$3.94M 0.02% 599
2023
Q1 		$247M Sell
3,256,271
-20,411
-0.6% -$1.41M 0.02% 627
2022
Q4 		$202M Sell
3,276,682
-663,474
-17% -$35.3M 0.02% 677
2022
Q3 		$164M Sell
3,940,156
-256,961
-6% -$11.2M 0.02% 750
2022
Q2 		$132M Buy
4,197,117
+1,949
+0% +$52K 0.01% 856
2022
Q1 		$113M Buy
4,195,168
+29,922
+0.7% +$536K 0.01% 1020
2021
Q4 		$79.8M Buy
4,165,246
+13,689
+0.3% +$343K 0.01% 1206
2021
Q3 		$137M Buy
4,151,557
+7,974
+0.2% +$244K 0.01% 974
2021
Q2 		$137M Buy
4,143,583
+242,764
+6% +$6.73M 0.01% 988
2021
Q1 		$162M Sell
3,900,819
-173,303
-4% -$5.33M 0.01% 882
2020
Q4 		$81.1M Buy
4,074,122
+863
+0% +$12.8K 0.01% 1128
2020
Q3 		$56.1M Buy
4,073,259
+121,737
+3% +$2.09M 0.01% 1149
2020
Q2 		$70.8M Buy
3,951,522
+769,188
+24% +$12M 0.01% 1023
2020
Q1 		$38.4M Buy
3,182,334
+7,786
+0.2% +$130K 0.01% 1127
2019
Q4 		$60.3M Buy
3,174,548
+6,740
+0.2% +$124K 0.01% 1128
2019
Q3 		$75.2M Buy
3,167,808
+795,247
+34% +$19.1M 0.01% 1005
2019
Q2 		$68.8M Buy
+2,372,561
New +$64.8M 0.01% 1074

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Fidelity Investments's TMDX Position: Q1 2026 in Review

Fidelity Investments increased its Transmedics (TMDX) stake by 0.38% in Q1 2026, buying an estimated $2.51M and bringing the position to 5,096,243 shares worth $507M. The position accounts for 0.03% of the portfolio, ranked #507.

Fidelity Investments first reported a position in TMDX in Q2 2019 and has held it in 28 quarters since. The position peaked at $676M in Q2 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Fidelity Investments held 5,096,243 shares of Transmedics worth $507M as of Q1 2026.
  • Fidelity Investments bought 19,207 Transmedics shares in Q1 2026, an estimated $2.51M.
  • Transmedics made up 0.03% of Fidelity Investments's portfolio in Q1 2026, its #507 holding.
  • Fidelity Investments first reported a position in Transmedics in Q2 2019 and has held it in 28 quarters since.
  • Fidelity Investments's Transmedics position peaked at $676M in Q2 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.